CHInese Medicine NeuroAid Efficacy on Stroke Recovery

Inclusion Criteria: * Subject is aged 18 years old and above (for Singapore 21 years and above as this is the legal age of consent) * Subject is on anti-platelet therapy * Subject is presented a pre-stroke Modified Rankin Scale inferior or equal to 1 * Female subject is eligible to participate in the trial if she is of non-childbearing potential (i.e. physiologically incapable of becoming pregnant, including any female who is post menopausal) * Subject or his/her legally acceptable representative is willing to provide written informed consent * Subject is presented with cerebral infarction with compatible imaging at Computed Tomography (CT) scan or Magnetic Resonance Imaging (MRI) * Time window is less than 72 hours after symptoms onset * Subject with cerebral infarction with intermediate severity range: 6 ≤ NIHSS ≤ 14 Exclusion Criteria: * Subjects deemed unstable by investigator after thrombolysis treatment * Subject has evidence of intra-cerebral hemorrhage on brain CT scan or MRI * Subject has a rapidly improving neurological deficit * Subject has definite indication for full-dose or long-term anticoagulation therapy * Subject has other significant non-ischemic brain lesion which could affect function disability * Subject has co-existing systemic diseases: terminal cancer, renal failure (creatinine \> 200 μmol/L, if known), cirrhosis, severe dementia or psychosis * Subject has participated in another clinical trial within the last three months